Improving cancer research and care for diverse populations in Hawaii
Official title: Developmental Research Program
Funded at University of Hawaii at Manoa · NIH-10931612 · Data updated 2026-11-12
This study is looking at how cancer affects different ethnic and cultural groups in Hawaii and the Pacific, with the goal of creating new treatments and tools that can help these communities better manage their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Hawaii at Manoa NIH-funded |
| Lab location | 1 site (Honolulu, United States) |
| Project start | September 19, 2023 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $106,173 |
| NIH project number | 5P20CA275734-02 |
| Project ID | NIH-10931612 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals from ethnic and racial minority groups in Hawaii who are at risk for or affected by cancer.
✕Less likely to help
Patients who do not belong to the targeted ethnic or racial groups may not receive direct benefits from this research.
What this research studies
The Developmental Research Program at the University of Hawai`i Cancer Center focuses on understanding cancer risk and outcomes among diverse ethnic and cultural groups in Hawaii and the Pacific. This program aims to foster research that translates findings into clinical trials and interventions tailored to the unique needs of these populations. By emphasizing community outreach and education, the program seeks to reduce the burden of cancer through innovative approaches that address specific health disparities. Patients may benefit from new therapies and diagnostic tools developed through this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cancer treatments and outcomes for diverse populations in Hawaii.
How similar studies have gone: Other research initiatives focusing on minority health have shown promise in improving cancer outcomes, suggesting that this approach could be effective.
Where this research is happening
-
University of Hawaii at Manoa
Honolulu, United States Active
Researchers
- Principal investigator: Maskarinec, Gertraud — University of Hawaii at Manoa
- Study coordinator: Maskarinec, Gertraud
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.